Moat Biotechnology is a clinical development stage biopharmaceutical company focused on the development of novel intranasal/inhaled and oral vaccines based on the SC-AdVax platform that was exclusively licensed from the Mayo Clinic.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/13/23 | $6,500,000 | Venture |
Boyd Street Ventures Cortado Ventures  | undisclosed |
